Form D · Biotechnology
INTACT VASCULAR, LLC
Wayne, PA · CIK 0001538367
Offering snapshot reported Feb 22, 2012 · SEC filing
- Reported sold
- $1.25M Offering amount: $3.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2012 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
| Jan 12, 2012 | Initial | $1,115,000 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-173794
Total offering amount does not include exercise price for warrants because exercise price is not yet known
Source: Form D, filed Feb 22, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carol A. Burns | Director, Executive |
| Katherine D. Crothall | Director |
| Robert Giasolli | Executive |
| Peter Schneider | Director, Executive |
| Brian Walsh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
325 West Avenue
Wayne, PA, 19087
Wayne, PA, 19087